Injections Promote “Wrong Antibodies” To Respond To Covid? - Part 1

Not sure if you’ve ever seen Moneyball, if you haven’t, check it out, as it’s a remarkably good movie. There is a great line in it where Brad Pitt’s character says, “if he’s a good hitter why doesn’t he hit good?” Applying it to our current day, “if the Covid vaccines work well why don’t they work well?”

You don’t have to take my word for it, just ask big pharma, following court-ordered document disclosures, the pharma companies suddenly and unexpectedly confessed this year that they “never studied whether the vaccines reduced transmission.” Well, that little tidbit would have been good to know right?

Which now leaves us with the all-important question of, so what exactly DID they study leading them to conclude that their pharmaceutical interventions were so effective?

Well in this Three part series titled "Injections Promote “Wrong Antibodies” To Respond To Covid? " I will discuss an explosive new study that could explain what's going wrong.

This first video lay the foundation about what we're going to discuss and the next two are information packed, given the importance of this information I strongly encourage you to watch all of them.

As always here are the links to all of the stories & studies cited in this video series.

Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
https://www.science.org/doi/10.1126/sciimmunol.ade2798

Cleveland Clinic Study
https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v1.full

Link to story about Kaiser Study
https://www.washingtonpost.com/health/2022/04/29/covid-deaths-unvaccinated-boosters/

Frontiers in Microbiology “Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections.”

https://www.frontiersin.org/articles/10.3389/fmicb.2022.1043049/full

New England Journal of Medicine “Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.”
https://www.nejm.org/doi/full/10.1056/NEJMc2202092

Yemen Journal of Medicine, “Immunoglobulin G4-related disease: A narrative review.”

https://www.researchgate.net/publication/362619065_Immunoglobulin_G4-related_disease_A_narrative_review

As always I welcome your thoughts & comments.
You can also follow me on Locals at https://kambrar.locals.com